Cellectis Presents Updated Clinical and Translational Data on BALLI-01 at the European Hematology Association (EHA) 2023

Written by Customer Service on June 9, 2023. Posted in Public Companies.

NEW YORK, June 09, 2023 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, presented today updated clinical and translational data on its clinical trial BALLI-01 (evaluating UCART22) at the European Hematology Association (EHA) 2023. The data presented support the preliminary safety and efficacy of UCART22 in a heavily pretreated relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL) population. “These clinical data are very positive for patients with r/r B-ALL who have failed multiple lines of treatment options including chemotherapy, CD19 directed CAR T-cell therapy and allogeneic stem cell transplant and encourage further enrollment into the BALLI-01...

U.S. Global Investors Reports Financial Results for the Second Quarter of Fiscal Year 2023

Written by Customer Service on June 9, 2023. Posted in Earnings Releases And Operating Results.

Long-Term U.S. Mutual Funds and ETFs Saw $370 Billion of Outflows in 2022 U.S. Global Investors SAN ANTONIO, June 09, 2023 (GLOBE NEWSWIRE) — U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm with longstanding experience in global markets and specialized sectors from gold mining to emerging markets, today reported operating income of $908,000 for the quarter ended December 31, 2022, on total revenues of $3.7 million. The Company recorded net income of $869,000, or $0.06 per share. Average assets under management (AUM) for the three-month period ended December 31, 2022, were $2.5 billion. Total AUM at December 31, 2022, was $2.4 billion, an increase of approximately $112 million from the previous quarter. The Company was delayed in submitting its financial results for the quarter...

USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States

Written by Customer Service on June 9, 2023. Posted in Public Companies.

Approved Study to Examine Tolerability of MDMA in Schizophrenia at UCLA VANCOUVER, British Columbia, June 09, 2023 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA)(OTC:PMBHF), a biotechnology company focused on the research, development, and manufacturing of MDXX class molecules (including MDMA), is pleased to report that the US Food and Drug Administration (USFDA) has approved a clinical trial utilizing PharmAla’s LaNeo MDMA Investigational Medical Product (IMP) capsules (40mg). This is the first time that PharmAla’s IMP has been approved for trial use in the United States. “While we’ve had great success with many regulators around the world, it’s still a major milestone to receive a stamp of approval from USFDA for our investigational drugs,” said Dr. Harpreet Kaur, Vice President of Research at...

Hainan Manaslu Acquisition Corp. Announces Additional Contribution to Trust Account to Further Extend Period to Consummate Business Combination

Written by Customer Service on June 9, 2023. Posted in Mergers And Acquisitions.

NEW YORK, June 09, 2023 (GLOBE NEWSWIRE) — Hainan Manaslu Acquisition Corp. (NASDAQ: HMACU, the “Company”), a special purpose acquisition company, announced today that Able View Inc. (“Able View”), has deposited into the Company’s trust account (the “Trust Account”) an aggregate amount of $227,700 (representing approximately $0.033 per public share), in order to extend the period of time the Company has to complete a business combination for an additional one (1) month period, from June 15, 2023 to July 14, 2023. The Company issued one unsecured promissory note in an amount of $227,700, to Able View with a principal amount equal to the amount deposited. The promissory note bears no interest and is convertible into the Company’s units (with each unit consisting of one ordinary share, one warrant to purchase one ordinary share,...

Winnebago Industries’ Michael Happe Named an EY Entrepreneur of The Year® 2023 Heartland Award Winner

Written by Customer Service on June 9, 2023. Posted in Public Companies.

Winnebago Industries President and CEO honored for leading transformational growth and fostering an entrepreneurial spirit across the company EDEN PRAIRIE, Minn., June 09, 2023 (GLOBE NEWSWIRE) — Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor lifestyle product manufacturer, is pleased to announce that President and CEO, Michael Happe, has been named a winner of the Ernst & Young Entrepreneur of The Year® Heartland Award. Honored for bringing a bold vision to Winnebago Industries when he joined the company in 2016, Happe has led the company through a significant evolution driven by organic and inorganic growth. The acquisitions of Grand Design, Chris-Craft, Newmar, and Barletta, as well as major growth of flagship brand, Winnebago, has created a leading company in the outdoor recreation industry. “I’m humbled and...

18/2023 Green Hydrogen Systems – Notification of transactions by persons discharging managerial responsibilities

Written by Customer Service on June 9, 2023. Posted in Public Companies.

Company announcement 18/2023 Notification of transactions by persons discharging managerial responsibilities in Green Hydrogen Systems A/S Kolding, Denmark, 9 June 2023 – In accordance with article 19 of the Market Abuse Regulation, Green Hydrogen Systems A/S (“Green Hydrogen Systems”) hereby notifies receipt of information of the following transactions made by persons discharging managerial responsibilities in Green Hydrogen Systems and persons closely associated with them in Green Hydrogen Systems’ shares and other financial instruments linked thereto: 1.Details of the person discharging managerial responsibilities/person closely associateda)NameSebastian Koks Andreassen2.Reason for the notificationa)Position/statusCEO in Green Hydrogen Systems A/Sb)Initial notification/amendmentInitial notification3.Details of the issuer, emission,...

PharmAla Awarded Research Grant by Ontario Centre for Innovation

Written by Customer Service on June 9, 2023. Posted in Public Companies.

OCI will support Pharmala’s In-Silico Modeling Partnership with University of Windsor TORONTO, June 09, 2023 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA)(OTC:PMBHF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including MDMA), is excited to announce that it has been granted a research grant by the Ontario Centre for Innovation in conjunction with the University of Windsor. “In-Silico Modeling is a crucial element of drug discovery, allowing for faster and more accurate prediction of which molecules will ‘hit’ our very specific targets, and thus be successful when sent to our pre-clinical partners at UAMS,” said Dr. Harpreet Kaur, PharmAla’s Vice President of Research. “While we have already been working closely with the team at...

TRILLION ENERGY SPUDS ALAPLI-2 WELL AT SASB GAS FIELD

Written by Customer Service on June 9, 2023. Posted in Public Companies.

Drilling of the sixth natural gas well at SASB has now begun Vancouver, B.C., June 09, 2023 (GLOBE NEWSWIRE) — Trillion Energy International Inc. (“Trillion” or the “Company”) (CSE: TCF) (OTCQB: TRLEF) (Frankfurt: Z62) announces the spudding of the Alapli-2 natural gas well at the SASB gas field, offshore Turkey, the sixth well in the Company’s multi-well program. Alapli-2 is a long-reach directional well being drilled from the Akkaya tripod and which will twin the Alapli-1 exploration well. The Alapli-1 well was never put on production but was perforated and tested at a combined rate of +7 MMcf/d, indicating the gas pool is economic. Update on Bayhanli-2 production The Bayhanli-2 gas well which commenced production on June 2, 2023 has averaged 8 MMcf/d (100%) of natural gas production in its first six full days of operation. Gas...

Circ re.Proposed Related Party Transaction

Written by Customer Service on June 9, 2023. Posted in Public Companies.

Downing Strategic Micro-Cap Investment Trust PLC (the “Company”)LEI Number: 213800QMYPUW4POFFX69Related Party Transaction, Publication of Circular and Notice of General Meeting9 June 2023 Introduction Further to the general meeting of the Company held on 20 February 2023, the Company announces that it has today published a circular (the “Circular“) and is convening a general meeting of the Company (the “General Meeting“) in order to propose a special resolution, which will, if passed, put all potentially affected parties so far as possible in the position in which they were always intended to be had the previously identified technical legal issue with the Company’s share capital structure not occurred. Background As explained in the circular published by the Company on 24 January 2023,...

Unity Bank Loan Supports Mountain Lakes Veteran Low Income Housing Project

Written by Customer Service on June 9, 2023. Posted in Public Companies.

Unity Sponsored Customer for $120,000 Affordable Housing Program Grant Mountain Lakes Groundbreaking Ceremony Attendees at a recent groundbreaking ceremony for a Mountain Lakes Veteran, low-income housing project at 367 Bloomfield Avenue (367 Route 46) partially funded by Unity Bank. MOUNTAIN LAKES, N.J., June 09, 2023 (GLOBE NEWSWIRE) — Unity Bank has provided a $350,000 commercial acquisition loan to Nouvelle, LLC of Franklin Lakes to help fund a four-unit disabled Veteran, low-income housing project at 367 Bloomfield Avenue, also known as 367 Route 46. Unity also sponsored Nouvelle for a $120,000 grant from the Federal Home Loan Bank of New York (FHLBNY) supporting the project. The FHLBNY Affordable Housing Program awards funds to the member lenders through a competitive process in order to support eligible projects that create...

Day: June 9, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice